Corneal complications after closed vitrectomy through the pars plana
H. D. Perry, G. N. Foulks, R. A. Thoft and F. I. Tolentino
A retrospective study of 150 patients who underwent closed vitrectomy
through the pars plana evaluated the incidence and character of
postoperative corneal complications. Corneal changes developed in 43% of
patients. Thirty patients had significant corneal complications, half of
which resolved with treatment. Fourteen patients had complications that
necessitated corneal surgery or resulted in loss of useful vision. Diabetic
patients were at greatest risk for corneal problems, particularly
postoperative epithelial defects. Intraoperative lensectomy was the only
other factor that increased the corneal complication rate. The importance
of early recognition and therapy for corneal changes after vitrectomy
becomes apparent.
A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients
Nakahara et al.
Br. J. Ophthalmol. 2005;89:266-268.
ABSTRACT
| FULL TEXT
Corneal Changes After Small-Incision Cataract Surgery in Patients With Diabetes Mellitus
Morikubo et al.
Arch Ophthalmol 2004;122:966-969.
ABSTRACT
| FULL TEXT
Noninvasive Assessment of Corneal Sensitivity in Young and Elderly Diabetic and Nondiabetic Subjects
Murphy et al.
IOVS 2004;45:1737-1742.
ABSTRACT
| FULL TEXT
Naltrexone, an Opioid Antagonist, Facilitates Reepithelialization of the Cornea in Diabetic Rat
Zagon et al.
Diabetes 2002;51:3055-3062.
ABSTRACT
| FULL TEXT
Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235
Fujishima and Tsubota
Br. J. Ophthalmol. 2002;86:860-863.
ABSTRACT
| FULL TEXT
Corneal Advanced Glycation End Products Increase in Patients With Proliferative Diabetic Retinopathy
Sato et al.
Diabetes Care 2001;24:479-482.
ABSTRACT
| FULL TEXT
Advanced Glycation End Products in Diabetic Corneas
Kaji et al.
IOVS 2000;41:362-368.
ABSTRACT
| FULL TEXT